Advertisement
Journal Home
Search for

582 Periodical Search Results

You searched for "metabolism" OR "metabolic pathway" OR "general metabolic function" within European Journal of Cancer

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 582 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

display abstract citation download email a colleague
Display:

  1. Methotrexate inhibits the glyoxalase system in vivo in children with acute lymphoid leukaemia
    Katalin Bartyik, Sandor Turi, Ferenc Orosz, Eszter Karg
    European Journal of Cancer
    October 2004 (Vol. 40, Issue 15, Pages 2287-2292)
    Abstract | Full Text | Full-Text PDF (343 KB)

  1. Pharmacokinetics of anticancer agents in patients with impaired liver function
    M.G. Donelli, M. Zucchetti, E. Munzone, M. D’Incalci, A. Crosignani
    European Journal of Cancer
    January 1998 (Vol. 34, Issue 1, Pages 33-46)
    Abstract | Full Text | Full-Text PDF (173 KB)

  1. Gene expression microarray technologies in the development of new therapeutic agents
    Paul A. Clarke, Robert te Poele, Paul Workman
    European Journal of Cancer
    November 2004 (Vol. 40, Issue 17, Pages 2560-2591)
    Abstract | Full Text | Full-Text PDF (750 KB)

  1. Comparison of 5-fluoro-2′-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer
    J.A.M. van Laar, Y.M. Rustum, S.P. Ackland, C.J. van Groeningen, G.J. Peters
    European Journal of Cancer
    February 1998 (Vol. 34, Issue 3, Pages 296-306)
    Abstract | Full Text | Full-Text PDF (146 KB)

  1. What does positron emission tomography offer oncology?
    H. Anderson, P. Price
    European Journal of Cancer
    October 2000 (Vol. 36, Issue 16, Pages 2028-2035)
    Abstract | Full Text | Full-Text PDF (658 KB)

  1. Clinical molecular imaging with positron emission tomography
    Azeem Saleem, Natalie Charnley, Pat Price
    European Journal of Cancer
    August 2006 (Vol. 42, Issue 12, Pages 1720-1727)
    Abstract | Full Text | Full-Text PDF (278 KB)

  1. Dosing strategies for anticancer drugs: the good, the bad and body-surface area
    A Felici, J Verweij, A Sparreboom
    European Journal of Cancer
    September 2002 (Vol. 38, Issue 13, Pages 1677-1684)
    Abstract | Full Text | Full-Text PDF (161 KB)

  1. Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity , 12 December 2007
    Sylvie M. Guichard, Janet S. Macpherson, Iain Mayer, Eilidh Reid, Morwenna Muir, Michael Dodds, Susan Alexander, Duncan I. Jodrell
    European Journal of Cancer
    January 2008 (Vol. 44, Issue 2, Pages 310-317)
    Abstract | Full Text | Full-Text PDF (195 KB)

  1. The spectrum of medical imaging
    T T. Jones
    European Journal of Cancer
    November 2002 (Vol. 38, Issue 16, Pages 2067-2069)
    Full Text | Full-Text PDF (72 KB)

  1. High expression of indoleamine 2,3-dioxygenase gene in prostate cancer , 11 July 2008
    Chantal Feder-Mengus, Stephen Wyler, Tvrtko Hudolin, Robin Ruszat, Lukas Bubendorf, Alberto Chiarugi, Maria Pittelli, Walter P. Weber, Alexander Bachmann, Thomas C. Gasser, Tullio Sulser, Michael Heberer, Giulio C. Spagnoli, Maurizio Provenzano
    European Journal of Cancer
    October 2008 (Vol. 44, Issue 15, Pages 2266-2275)
    Abstract | Full Text | Full-Text PDF (331 KB)

  1. Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancer
    T Kasai, M Oka, H Soda, J Tsurutani, M Fukuda, Y Nakamura, S Kawabata, K Nakatomi, S Nagashima, H Takatani, M Fukuda, A Kinoshita, S Kohno
    European Journal of Cancer
    September 2002 (Vol. 38, Issue 14, Pages 1871-1878)
    Abstract | Full Text | Full-Text PDF (136 KB)

  1. Emergencies and their management
    G Nicolin
    European Journal of Cancer
    July 2002 (Vol. 38, Issue 10, Pages 1365-1377)
    Full Text | Full-Text PDF (154 KB)

  1. Ifosfamide nephrotoxicity: Limited influence of metabolism and mode of administration during repeated therapy in paediatrics
    A.V. Boddy, M. English, A.D.J. Pearson, J.R. Idle, R. Skinner
    European Journal of Cancer
    June 1996 (Vol. 32, Issue 7, Pages 1179-1184)
    Abstract | Abstract + References | Full-Text PDF (793 KB)

  1. Adenoviral-mediated transfer of Escherichia coli uracil phosphoribosyltransferase (UPRT) gene to modulate the sensitivity of the human colon cancer cells to 5-fluorouracil
    F Koyama, H Sawada, H Fujii, H Hamada, T Hirao, M Ueno, H Nakano
    European Journal of Cancer
    December 2000 (Vol. 36, Issue 18, Pages 2403-2410)
    Abstract | Full Text | Full-Text PDF (242 KB)

  1. Multi-species toxicology approaches for oncology drugs: the US perspective
    Joseph E. Tomaszewski
    European Journal of Cancer
    April 2004 (Vol. 40, Issue 6, Pages 907-913)
    Abstract | Full Text | Full-Text PDF (150 KB)

  1. RNF11 is a multifunctional modulator of growth factor receptor signalling and transcriptional regulation
    Peter Azmi, Arun Seth
    European Journal of Cancer
    November 2005 (Vol. 41, Issue 16, Pages 2549-2560)
    Abstract | Full Text | Full-Text PDF (307 KB)

  1. Genotyping and phenotyping cytochrome P450: Perspectives for cancer treatment
    Ron H.J. Mathijssen, Ron H.N. van Schaik
    European Journal of Cancer
    January 2006 (Vol. 42, Issue 2, Pages 141-148)
    Abstract | Full Text | Full-Text PDF (160 KB)

  1. Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?
    Eric Assenat, Sabine Gerbal-chaloin, Patrick Maurel, Marie José Vilarem, Jean Marc Pascussi
    European Journal of Cancer
    April 2006 (Vol. 42, Issue 6, Pages 785-792)
    Abstract | Full Text | Full-Text PDF (167 KB)

  1. β-Adrenoceptor activity and resting energy metabolism in weight losing cancer patients
    A. Hyltander, P. Daneryd, R. Sandström, U. Körner, K. Lundholm
    European Journal of Cancer
    February 2000 (Vol. 36, Issue 3, Pages 330-334)
    Abstract | Full Text | Full-Text PDF (98 KB)

  1. Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1α involvement in CYP3A4 repression , 20 August 2009
    Claire Legendre, Tamaki Hori, Pascal Loyer, Caroline Aninat, Seiichi Ishida, Denise Glaise, Catherine Lucas-Clerc, Karim Boudjema, Christiane Guguen-Guillouzo, Anne Corlu, Fabrice Morel
    European Journal of Cancer
    November 2009 (Vol. 45, Issue 16, Pages 2882-2892)
    Abstract | Full Text | Full-Text PDF (671 KB) | Add-Ons
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 582 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement